Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    "Hepatitis E"
Show Display Options
Rank Status Study
1 Completed A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Condition: Hepatitis E
Intervention: Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
2 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
Intervention:
3 Active, not recruiting Clinical Trial of Recombinant Hepatitis E Vaccine
Condition: Hepatitis E
Interventions: Biological: hepatitis E vaccine;   Biological: Hepatitis B vaccine
4 Completed A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
Condition: Hepatitis E
Interventions: Biological: 30μg/0.5ml Hepatitis E vaccine;   Biological: 30μg/0.5ml Recombinant Hepatitis E vaccine
5 Unknown  Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)
Condition: Hepatitis E
Intervention: Biological: Recombinant (E. Coli) Hepatitis E Vaccine
6 Active, not recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
Condition: Hepatitis E
Intervention: Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
7 Not yet recruiting Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.
Condition: Hepatitis E Infection
Interventions: Drug: Hecolin;   Drug: Hepa-B
8 Recruiting Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
Condition: Hepatitis E
Intervention: Drug: Ribavirin
9 Recruiting Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
Conditions: HIV;   Hepatitis E
Intervention:
10 Enrolling by invitation The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors
Condition: Chronic Hepatitis E
Intervention: Behavioral: questionnaires
11 Recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
Conditions: Hepatitis E;   Hepatitis B
Interventions: Biological: HEV vaccine;   Biological: HBV vaccine
12 Completed Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
Condition: Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
Intervention: Other: blood samples
13 Active, not recruiting Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis Patients
Condition: Hepatitis E Virus Infection
Intervention:
14 Recruiting A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus
Conditions: Acute on Chronic Hepatic Failure;   Liver Failure;   Hepatitis E Infection
Interventions: Drug: Ribavirin;   Drug: Placebo
15 Recruiting Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study
Condition: Transplantation
Intervention: Biological: Hepatitis E serology
16 Completed Role of Cytokines in Hepatitis E Virus Infection During Pregnancy
Conditions: Hepatitis;   Cytokines;   Pregnancy
Intervention:
17 Completed A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.
Condition: Hepatitis
Intervention: Biological: Hepatitis E vaccine, recombinant (Sar 56 kDa)
18 Active, not recruiting Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer;   Vaginal Intraepithelial Neoplasia;   Vulvar Intraepithelial Neoplasia;   Persistent Infection
Interventions: Biological: HPV Vaccine;   Biological: HEV vaccine
19 Terminated Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Conditions: Acute Hepatitis A;   Acute Hepatitis B;   Acute Hepatitis C;   Acute Hepatitis E;   Acute EBV Hepatitis;   Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin;   Other: Lactose monohydrate
20 Completed Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
Condition: Chronic Hepatitis B
Intervention: Drug: HBsAg vaccine with Entecavir

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.